Artigos de revistas sobre o tema "Papillomavirus humain (HPV)"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Papillomavirus humain (HPV)".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Ouedraogo, Rogomenoma Alice, Théodora Mahoukèdè Zohoncon, Abdoul Karim Ouattara e Jacques Simpore. "Prédominance du papillomavirus humain 56 dans une sous-population de femmes sexuellement actives à Garango, Centre-Est, Burkina Faso." Journal of Applied Biosciences 150 (30 de junho de 2020): 15499–509. http://dx.doi.org/10.35759/jabs.150.10.
Texto completo da fonteGavillon, N., H. Vervaet, E. Derniaux, P. Terrosi, O. Graesslin e C. Quereux. "Papillomavirus humain (HPV) : comment ai-je attrapé ça ?" Gynécologie Obstétrique & Fertilité 38, n.º 3 (março de 2010): 199–204. http://dx.doi.org/10.1016/j.gyobfe.2010.01.003.
Texto completo da fonteEzebialu, C. U., I. U. Ezebialu e C. C. Ezenyeaku. "Persistence of cervical human papillomavirus infection among cohort of women in Awka, Nigeria". African Journal of Clinical and Experimental Microbiology 22, n.º 3 (2 de julho de 2021): 344–51. http://dx.doi.org/10.4314/ajcem.v22i3.5.
Texto completo da fonteManus, Jean-Marie. "Brève : Vaccin à papillomavirus humain (HPV) pour filles et garçons". Revue Francophone des Laboratoires 2021, n.º 529 (fevereiro de 2021): 19. http://dx.doi.org/10.1016/s1773-035x(21)00026-5.
Texto completo da fonteMacdonald, Liane, Shelley Deeks e Carolyn Doyle. "A Public Health Perspective on HPV Vaccination: Response to The HPV Vaccination Campaign: A Project of Moral Regulation in an Era of Biopolitics". Canadian Journal of Sociology 35, n.º 4 (28 de setembro de 2010): 627–32. http://dx.doi.org/10.29173/cjs8977.
Texto completo da fonteOumara, M., S. Guede, Abdou A. Issa, Garba S. Oumarou, Diaouga H. Soumana, Lankoande Z. Salifou, Yacouba M. Chaibou, R. M. Garba e M. Nayama. "Epidémiologie et génotypage du papillomavirus humain au Niger : A propos de 30 cas au Centre National Santé de la Reproduction de Niamey". Journal de la Recherche Scientifique de l’Université de Lomé 26, n.º 1 (18 de abril de 2024): 177–86. http://dx.doi.org/10.4314/jrsul.v26i1.24.
Texto completo da fontePerrin, Andry. "Vaccination contre le papillomavirus humain (HPV) chez le sujet masculin : évidence et pratique". Revue Médicale Suisse 15, n.º 673 (2019): 2202–4. http://dx.doi.org/10.53738/revmed.2019.15.673.2202.
Texto completo da fonteFarge, G., E. Guyot, M. Belhassen, M. Bérard, F. Jacoud, L. Bensimon, G. De pouvourville e J. Baldauf. "Couverture vaccinale contre le papillomavirus humain (HPV) chez les adolescents français: étude PAPILLON". Gynécologie Obstétrique Fertilité & Sénologie 52, n.º 5 (maio de 2024): 349. http://dx.doi.org/10.1016/j.gofs.2024.03.016.
Texto completo da fonteGuyot, E., G. Farge, M. Belhassen, M. Berard, F. Jacoud, L. Bensimon, G. de Pouvourville e J.-J. Baldauf. "Couverture vaccinale contre le papillomavirus humain (HPV) chez les adolescents français - Étude PAPILLON". Journal of Epidemiology and Population Health 72 (março de 2024): 202216. http://dx.doi.org/10.1016/j.jeph.2024.202216.
Texto completo da fonteDib, Fadia, Gwenn Menvielle e Pierre Chauvin. "Tous égaux face aux papillomavirus ? L’infection et la vaccination HPV au prisme des inégalités sociales de santé". Questions de santé publique, n.º 38 (novembro de 2019): 1–8. http://dx.doi.org/10.1051/qsp/2019038.
Texto completo da fonteAdejo, D. S., M. Aminu, E. E. Ella, O. A. Oguntayo e O. F. Obishakin. "Prevalence of high-risk human papillomavirus genotypes among apparently healthy women with normal and abnormal cervical cytology in Kaduna State, Nigeria". African Journal of Clinical and Experimental Microbiology 25, n.º 1 (16 de janeiro de 2024): 17–27. http://dx.doi.org/10.4314/ajcem.v25i1.3.
Texto completo da fontePépin, Dominique, Johanne Le Bihan-Le Beyec, Danièle Hugol, Jacques Diebold, Anne Gompel, Jean Chambaz e Jean-Marc Lacorte. "Stratégie de dépistage par PCR des infections a papillomavirus humain (HPV) sur les prélèvements cervico-vaginaux". Revue Française des Laboratoires 1999, n.º 318 (dezembro de 1999): 23–28. http://dx.doi.org/10.1016/s0338-9898(99)80419-3.
Texto completo da fonteRiethmuller, D., C. Gabelle, R. Ramanah, J. L. Sautière, J. L. Prétet, J. P. Schaal, B. Kantelip, C. Mougin e R. Maillet. "Intérêt de la recherche du papillomavirus humain (HPV) dans le suivi post-conisation des CIN2–3". Journal de Gynécologie Obstétrique et Biologie de la Reproduction 37, n.º 4 (junho de 2008): 329–37. http://dx.doi.org/10.1016/j.jgyn.2007.12.012.
Texto completo da fonteWafo, E., D. Ivorra-Deleuze, C. Thuillier e R. Rouzier. "Estimation de l’évolution des connaissances sur les infections à Papillomavirus humain (HPV) : résultats d’une enquête téléphonique". Journal de Gynécologie Obstétrique et Biologie de la Reproduction 39, n.º 4 (junho de 2010): 305–9. http://dx.doi.org/10.1016/j.jgyn.2010.03.007.
Texto completo da fonteBaldauf, J., G. Farge, E. Guyot, M. Belhassen, M. Bérard, F. Jacoud, L. Bensimon e G. De Pouvourville. "Couverture vaccinale contre le papillomavirus humain (HPV) chez les adolescents français et inégalités sociales : Étude PAPILLON". Médecine et Maladies Infectieuses Formation 3, n.º 2 (junho de 2024): S130—S131. http://dx.doi.org/10.1016/j.mmifmc.2024.04.365.
Texto completo da fonteMezin, Laetitia, Anne Rousseau, Yann Sellier, Luis Teixeira, Clémence Schantz e Vaxi-Pap. "« Un vaccin qui reste quand même à part » : Papillomavirus et vaccination en France". Santé Publique Vol. 35, n.º 2 (2 de agosto de 2023): 127–37. http://dx.doi.org/10.3917/spub.232.0127.
Texto completo da fonteBOUSSAGEON, R., E. FERRAT, M. FLORI, S. ERPELDINGER, C. MAYNIE-FRANCOIS, I. SUPPER e D. POUCHAIN. "Vaccin HPV et prévention du cancer du col de l’utérus". EXERCER 31, n.º 165 (1 de setembro de 2020): 310–15. http://dx.doi.org/10.56746/exercer.2020.165.310.
Texto completo da fonteIsmail, S., e S. Deeks. "Résumé de la mise à jour du Comité consultatif national de l’immunisation visant le calendrier d’immunisation recommandé pour le vaccin contre le virus du papillome humain". Relevé des maladies transmissibles au Canada 41, S3 (20 de abril de 2015): 12–14. http://dx.doi.org/10.14745/ccdr.v41is3a03f.
Texto completo da fonteTotten, S., A. Severini, GC Jayaraman, ST Faybush, G. Johnson, AA Demers, I. Sobol, Y. Mao e Wong Wong. "Résultats des infections au virus du papillome humain (VPH) spécifiques au type et des tests Pap chez les femmes inuites et non inuites au Nunavut, Canada". Relevé des maladies transmissibles au Canada 41, n.º 3 (5 de março de 2015): 46–54. http://dx.doi.org/10.14745/ccdr.v41i03a01f.
Texto completo da fonteTunis, MC, e SL Deeks. "Résumé des recommandations mises à jour du Comité consultatif national de l’immunisation sur les vaccins contre le virus du papillome humain (VPH) : Intervalles minimaux entre les doses du vaccin nonavalent contre le VPH dans le calendrier d’immunisation contre le VPH". Relevé des maladies transmissibles au Canada 42, n.º 7 (7 de julho de 2016): 166–69. http://dx.doi.org/10.14745/ccdr.v42i07a03f.
Texto completo da fonteDeeks, SL, MC Tunis e S. Ismail. "Résumé de la mise à jour du CCNI sur l'utilisation recommandée du vaccin contre le virus du papillome humain (VPH) : Calendrier de vaccination du vaccin nonavalent contre le VPH à deux doses et utilisation des vaccins anti-VPH chez les populations". Relevé des maladies transmissibles au Canada 43, n.º 6 (1 de junho de 2017): 155–59. http://dx.doi.org/10.14745/ccdr.v43i06a04f.
Texto completo da fonteQədir qızı Əbilova, Rübayə, Gülnarə Alışa qızı Cəfərova e Hafiz Maarif oğlu Osmanov. "The role of viruses and bacteria in the development of cancer". NATURE AND SCIENCE 11, n.º 06 (23 de agosto de 2021): 5–10. http://dx.doi.org/10.36719/2707-1146/11/5-10.
Texto completo da fonteWanja Karani, Lucy, Stanslaus Musyoki, Robert Orina, Christopher Khayeka-Wandabwa e Benuel Nyagaka. "Cytological physiognomies and genotype distribution of human papillomaviruses among HPV/HIV co-infected and HPV mono-infected women". African Health Sciences 21, n.º 1 (16 de abril de 2021): 254–62. http://dx.doi.org/10.4314/ahs.v21i1.33.
Texto completo da fonteFrancies, Flavia Zita, e Zodwa Dlamini. "Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies". Cells 10, n.º 2 (26 de janeiro de 2021): 239. http://dx.doi.org/10.3390/cells10020239.
Texto completo da fonteBigoni, Jérôme, Rosa Catarino, Caroline Benski, Manuela Viviano, Maria Munoz, Honoré Tilahizandry, Patrick Petignat e Pierre Vassilakos. "High Burden of Human Papillomavirus Infection in Madagascar: Comparison With Other Sexually Transmitted Infections". Infectious Diseases: Research and Treatment 11 (1 de janeiro de 2018): 117863371775268. http://dx.doi.org/10.1177/1178633717752686.
Texto completo da fonteConway, M. J., e C. Meyers. "Replication and Assembly of Human Papillomaviruses". Journal of Dental Research 88, n.º 4 (abril de 2009): 307–17. http://dx.doi.org/10.1177/0022034509333446.
Texto completo da fonteVarsani, Arvind, Eric van der Walt, Livio Heath, Edward P. Rybicki, Anna Lise Williamson e Darren P. Martin. "Evidence of ancient papillomavirus recombination". Journal of General Virology 87, n.º 9 (1 de setembro de 2006): 2527–31. http://dx.doi.org/10.1099/vir.0.81917-0.
Texto completo da fonteGudenkauf, Franciska J., e Aaron P. Thrift. "Racial/Ethnic Differences in Cancers Attributable to Preventable Infectious Agents in Texas, 2015". Public Health Reports 135, n.º 6 (20 de outubro de 2020): 805–12. http://dx.doi.org/10.1177/0033354920954497.
Texto completo da fonteAlberts, Catharina J., Isabelle Heard, Ana Canestri, Lucie Marchand, Jean-François Fléjou, Lionel Piroth, Tristan Ferry et al. "Incidence and Clearance of Anal Human Papillomavirus (HPV)-16 and HPV-18 Infection, and Their Determinants, Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in France". Journal of Infectious Diseases 221, n.º 9 (22 de novembro de 2019): 1488–93. http://dx.doi.org/10.1093/infdis/jiz623.
Texto completo da fonteBieńkowski, Carlo, Zuzanna Żak, Filip Fijołek, Martyna Cholewik, Maciej Stępień, Agata Skrzat-Klapaczyńska e Justyna D. Kowalska. "Immunological and Clinical Responses to Vaccinations among Adults Living with HIV". Life 14, n.º 5 (24 de abril de 2024): 540. http://dx.doi.org/10.3390/life14050540.
Texto completo da fonteMakhorina, T. V., K. E. Boeva, G. V. Malyshkina e A. V. Semenov. "MECHANISMS OF EVACUATION OF THE HUMAN PAPILLOMA VIRUS FROM THE IMMUNE RESPONSE IN HIV-INFECTED PEOPLE". Laboratornaya i klinicheskaya meditsina. Farmatsiya, n.º 8 (2023): 46–59. http://dx.doi.org/10.14489/lcmp.2023.02.pp.046-059.
Texto completo da fonteMbimenyuy, C. M., J. F. Cho, A. E. Mugyia, G. M. Ikomey, D. M. Tebit e D. A. Nota. "Comparative HPV genotype distribution among women with normal and abnormal cervical cytology in Yaoundé, Cameroon". African Journal of Clinical and Experimental Microbiology 24, n.º 2 (18 de abril de 2023): 158–67. http://dx.doi.org/10.4314/ajcem.v24i2.5.
Texto completo da fonteAwua, Adolf K., Alberto Severini, Edwin K. Wiredu, Edwin A. Afari, Vanessa A. Zubach e Richard M. K. Adanu. "Self-Collected Specimens Revealed a Higher Vaccine- and Non-Vaccine-Type Human Papillomavirus Prevalences in a Cross-Sectional Study in Akuse". Advances in Preventive Medicine 2020 (22 de janeiro de 2020): 1–13. http://dx.doi.org/10.1155/2020/8343169.
Texto completo da fonteSharipova, I. P., e E. I. Musabaev. "HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL CANCER (OWERWIEW)". UZBEK MEDICAL JOURNAL 2, n.º 4 (30 de abril de 2021): 23–29. http://dx.doi.org/10.26739/2181-0664-2021-4-4.
Texto completo da fonteSyrjänen, S. "Human Papillomavirus Infection and Its Association with HIV". Advances in Dental Research 23, n.º 1 (25 de março de 2011): 84–89. http://dx.doi.org/10.1177/0022034511399914.
Texto completo da fonteVolgareva, G. M. "PAPILLOMAVIRAL CARCINOGENESIS. SIGNIFICANT ACHIEVEMENTS AND SPECIFIC CHALLENGES. PART 3. THREE LEVELS OF CERVICAL CANCER PREVENTION AND TREATMENT". Russian Journal of Biotherapy 19, n.º 3 (13 de outubro de 2020): 6–11. http://dx.doi.org/10.17650/1726-9784-2020-19-3-6-11.
Texto completo da fonteTong, Yan, Philip Tonui, Aaron Ermel, Omenge Orang’o, Nelson Wong, Maina Titus, Stephen Kiptoo, Kapten Muthoka, Patrick J. Loehrer e Darron R. Brown. "Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in Kenyan women". SAGE Open Medicine 8 (janeiro de 2020): 205031212094513. http://dx.doi.org/10.1177/2050312120945138.
Texto completo da fonteYao, Pang, Iona Millwood, Christiana Kartsonaki, Alexander J. Mentzer, Naomi Allen, Rima Jeske, Julia Butt et al. "Sero-prevalence of 19 infectious pathogens and associated factors among middle-aged and elderly Chinese adults: a cross-sectional study". BMJ Open 12, n.º 5 (maio de 2022): e058353. http://dx.doi.org/10.1136/bmjopen-2021-058353.
Texto completo da fonteLópez-Martínez, Jael, María del Pilar Gabriel de la Torre, Cristian Cruz Ochoa, Lucía Martínez-Martínez e Miguel Ángel Mayoral Chávez. "Los virus como detonante oncogénico". Tequio 1, n.º 2 (27 de janeiro de 2018): 57–67. http://dx.doi.org/10.53331/teq.v1i2.5493.
Texto completo da fonteKAWANA, Kei. "Human papillomavirus prophylactic vaccine". Uirusu 62, n.º 1 (2012): 79–86. http://dx.doi.org/10.2222/jsv.62.79.
Texto completo da fonteZou, Nianxiang, Jen-Sing Liu, Shu-Ru Kuo, Thomas R. Broker e Louise T. Chow. "The Carboxyl-Terminal Region of the Human Papillomavirus Type 16 E1 Protein Determines E2 Protein Specificity during DNA Replication". Journal of Virology 72, n.º 4 (1 de abril de 1998): 3436–41. http://dx.doi.org/10.1128/jvi.72.4.3436-3441.1998.
Texto completo da fonteRomero-Masters, James C., Paul F. Lambert e Karl Munger. "Molecular Mechanisms of MmuPV1 E6 and E7 and Implications for Human Disease". Viruses 14, n.º 10 (28 de setembro de 2022): 2138. http://dx.doi.org/10.3390/v14102138.
Texto completo da fonteWhite, Wendy I., Susan D. Wilson, William Bonnez, Robert C. Rose, Scott Koenig e Joann A. Suzich. "In Vitro Infection and Type-Restricted Antibody-Mediated Neutralization of Authentic Human Papillomavirus Type 16". Journal of Virology 72, n.º 2 (1 de fevereiro de 1998): 959–64. http://dx.doi.org/10.1128/jvi.72.2.959-964.1998.
Texto completo da fonteKing, Caroline C., Denise J. Jamieson, Jeffrey Wiener, Susan Cu-Uvin, Robert S. Klein, Anne M. Rompalo, Keerti V. Shah e Jack D. Sobel. "Bacterial Vaginosis and the Natural History of Human Papillomavirus". Infectious Diseases in Obstetrics and Gynecology 2011 (2011): 1–8. http://dx.doi.org/10.1155/2011/319460.
Texto completo da fonteSano, Takaaki. "Human Papillomavirus (HPV) Infection and Immunohistochemistry". Kitakanto Medical Journal 64, n.º 4 (2014): 347–48. http://dx.doi.org/10.2974/kmj.64.347.
Texto completo da fontePrelić, Jovana, e Aleksandra Knežević. "The frequency of infection with high-risk human papilloma virus types on the cervix uteri of women of reproductive age". Medicinski podmladak 73, n.º 1 (2022): 55–61. http://dx.doi.org/10.5937/mp73-33477.
Texto completo da fonteNG, García. "Polymorphism of KIR Genes in Women with Human Papillomavirus Infection". Virology & Immunology Journal 7, n.º 3 (7 de julho de 2023): 1–4. http://dx.doi.org/10.23880/vij-16000319.
Texto completo da fonteKornete, Anna, Elizabete Pumpure, Jana Zodzika, Dace Rezeberga, Liga Puksta-Gulbe e Irina Jermakova. "Human Immunodeficiency Virus and Human Papillomavirus Co-Infection in Pregnant Woman". Acta Chirurgica Latviensis 16, n.º 2 (1 de dezembro de 2016): 26–27. http://dx.doi.org/10.1515/chilat-2017-0006.
Texto completo da fonteTesfalul, Martha, Kenneth Simbiri, Chikoti M. Wheat, Didintle Motsepe, Hayley Goldbach, Kathleen Armstrong, Kathryn Hudson, Mukendi K. Kayembe, Erle Robertson e Carrie Kovarik. "Oncogenic Viral Prevalence in Invasive Vulvar Cancer Specimens From Human Immunodeficiency Virus–Positive and -Negative Women in Botswana". International Journal of Gynecologic Cancer 24, n.º 4 (maio de 2014): 758–65. http://dx.doi.org/10.1097/igc.0000000000000111.
Texto completo da fonteDelany-Moretlwe, Sinead, A. Chikandiwa e J. Gibbs. "Human papillomavirus infection and disease in men: Impact of HIV". Southern African Journal of HIV Medicine 14, n.º 4 (22 de novembro de 2013): 183–88. http://dx.doi.org/10.4102/sajhivmed.v14i4.55.
Texto completo da fonte